Japan’s JCR Pharmaceuticals (TYO: 4552) closed 15% higher after Wednesday’s trading, as it signed a new licensing deal.

US pharma giant Merck & Co today revealed it has made a bid to acquire UK-based lung therapy company Verona Pharma, sending ...

New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...

A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...

French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.

Donald Trump has escalated his warnings to the pharmaceutical industry with a pledge to introduce import tariffs as high as ...

Debra Barker has been named chief medical officer (CMO) at Centauri Therapeutics, a UK immunotherapy company with a ...

Prior to joining Crescent, Dr Pinkas was CSO at Pyxis Oncology (Nasdaq: PYXS), where he established the preclinical research ...

Diagonal Therapeutics, a US biotech focused on correcting dysregulated signaling with clustering antibodies that address the ...

San Francisco, USA-based biotech Centivax, which is developing durable, universal vaccines, today announced the close of a ...